Latest immunotherapy news
One Year of Abatacept Delays Progression to RA for Up to Four Years in At-Risk Population
posted January 23rd
by modernClinician Editorial Team
by modernClinician Editorial Team
Recommendations Developed for Optimizing Biologics in Adults With Severe Asthma
posted January 22nd
by modernClinician Editorial Team
by modernClinician Editorial Team
Progression-Free Survival Prolonged With Sacituzumab Govitecan Plus Pembrolizumab in TNBC
posted January 22nd
by modernClinician Editorial Team
by modernClinician Editorial Team
Circulating Tumor DNA Linked to Poor Prognosis in HER2-Positive Early Breast Cancer
posted January 15th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Response to Autologous HSCT Durable for Patients With Systemic Sclerosis 
Treatment Satisfaction Higher for Patients With RA Choosing Their Own Treatment 
Early Survivorship Care Linked to Improved Outcomes in Head, Neck Cancer 
Drug Interactions Reducing Contraceptive Effectiveness Common in Epilepsy Related Articles
Blinatumomab Improves Event-Free Survival in Children With High-Risk B-Cell ALL 
Rheumatic Immune-Related AEs With Immune Checkpoint Inhibitors More Severe Than Previously Reported 
Thymic Radiation Linked to Worse Outcomes in Patients With NSCLC 
Preoperative Chemo + Immunotherapy Combo Shrinks Head, Neck Cancer Tumors Monthly Specialist Briefings
Stay Connected
